ABL Bio has ranked among the top searched stocks for 8 days in the past month.

As of 12:30 PM on the 18th, ABL Bio is trading at 37,450 KRW, up 16.3% from the previous day. This marks a 105.77% increase compared to May 27. ABL Bio is known as a specialized company developing bio-pharmaceuticals based on antibody therapeutics.

Today, foreigners have net purchased 38,000 shares of ABL Bio, while institutions have net sold 5,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 169,205 shares, whereas foreigners and institutions have net sold 67,683 shares and 48,382 shares respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm’s IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing